Home > Healthcare > Medical Devices > Diagnostic Devices > Hemodynamic Monitoring Devices Market

Hemodynamic Monitoring Devices Market Size

  • Report ID: GMI7995
  • Published Date: Jan 2024
  • Report Format: PDF

Hemodynamic Monitoring Devices Market Size

Hemodynamic Monitoring Devices Market size was valued at around USD 1.5 billion in 2023 and is estimated to observe around 5.9% CAGR from 2023 to 2032. Hemodynamic monitoring devices are medical instruments designed to measure and assess various aspects of the cardiovascular system's functioning. These devices provide real-time information about the heart's pumping ability, blood circulation, and other hemodynamic parameters.

 

The growth of hemodynamic monitoring devices can be attributed to various factors, including ongoing advancements in hemodynamic monitoring devices, increasing prevalence of chronic diseases, rising demand for telehealth services, continual growth of healthcare expenditure, and an escalating inclination towards remote patient monitoring devices, which accounted for USD 14 billion in 2022, among other contributing factors.

 

Furthermore, anticipated market expansion is attributed to multiple factors, including the rising incidence of cardiovascular, chronic obstructive pulmonary (COPD), and respiratory ailments, the emergence of innovative non-invasive & minimally invasive systems, and swift advancements in surgical procedures. For instance, in 2021, according to the American Lung Association, COPD prevalence in the U.S. was approximated at 6.5% of the overall population, which is estimated 14.2 million.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Hemodynamic monitoring devices industry size was USD 1.5 billion in 2023 and is estimated to surpass USD 2.5 billion by 2032 owing to the ongoing advancements in hemodynamic monitoring devices.

Hemodynamic monitoring devices industry from the hemodynamic monitors segment generated USD 918.5 million in 2023 and will grow substantially through 2032 owing to the increasing investments from leading manufacturers to create patient-centric care and introduce technologically advanced products.

North America hemodynamic monitoring devices industry size accounted for USD 603.6 million in 2023 and is set to exhibit robust growth through 2032 owing to the presence of sophisticated healthcare infrastructure and the heightened prevalence of cardiovascular diseases in the region.

Top firms engaged in the hemodynamic monitoring devices industry are Becton, Dickinson and Company, Baxter International Inc., Deltex Medical Group PLC, Edwards Lifesciences Corporation, GE HealthCare, ICU Medical, Inc., Koninklijke Philips N.V., Medtronic plc, Nihon Kohden Corporation, OsypkaCardiotek GmbH, Siemens Healthineers AG, and Sramek BioDynamics, Inc.

Hemodynamic Monitoring Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 13
  • Tables & Figures: 206
  • Countries covered: 22
  • Pages: 114
 Download Free Sample